Clinically relevant immunosuppressants influence UVB-induced tumor size through effects on inflammation and angiogenesis.

Clinically relevant immunosuppressants influence UVB-induced tumor size through effects on inflammation and angiogenesis.

Item
http://www.wikidata.org/entity/Q46946071
Incidence, risk factors and outcomes of de novo malignancies post liver transplantationSkin cancer in solid organ transplant recipients: are mTOR inhibitors a game changer?Pathogenesis of nonmelanoma skin cancers in organ transplant recipientsInhibition of Akt Enhances the Chemopreventive Effects of Topical Rapamycin in Mouse Skin.Sirolimus reduces the incidence and progression of UVB-induced skin cancer in SKH mice even with co-administration of cyclosporine A.Chromosomal aberrations in UVB-induced tumors of immunosuppressed mice.Topical treatment with black raspberry extract reduces cutaneous UVB-induced carcinogenesis and inflammation.Celecoxib reduces the effects of acute and chronic UVB exposure in mice treated with therapeutically relevant immunosuppressive drugs.Critical review of preclinical approaches to evaluate the potential of immunosuppressive drugs to influence human neoplasia.Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update.Exposure to moxifloxacin and cytomegalovirus replication is associated with skin squamous cell carcinoma development in lung transplant recipients.A surveillance model for skin cancer in organ transplant recipients: a 22-year prospective study in an ethnically diverse population.
P2860

Clinically relevant immunosuppressants influence UVB-induced tumor size through effects on inflammation and angiogenesis.

Item
http://www.wikidata.org/entity/Q46946071
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Clinically relevant immunosupp ...... inflammation and angiogenesis.
@en
Clinically relevant immunosupp ...... inflammation and angiogenesis.
@nl
type
label
Clinically relevant immunosupp ...... inflammation and angiogenesis.
@en
Clinically relevant immunosupp ...... inflammation and angiogenesis.
@nl
prefLabel
Clinically relevant immunosupp ...... inflammation and angiogenesis.
@en
Clinically relevant immunosupp ...... inflammation and angiogenesis.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Clinically relevant immunosupp ...... inflammation and angiogenesis
@en
P2093
P2860
P304
P31
P356
10.1111/J.1600-6143.2007.02004.X
P407
P433
P478
P50
P577
P5875
P698
P921